Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Olaf Randerath"'
Autor:
Christian Beger, Astrid Mayerböck, Konrad Klein, Theresa Karg, Kai M. Schmidt-Ott, Olaf Randerath, Florian P. Limbourg
Publikováno v:
Blood Pressure, Vol 32, Iss 1 (2023)
Purpose Discrepancies exist between guideline recommendations and real-world practice of blood pressure (BP) measurements. The aim of this study was to assess, with a nationwide, questionnaire-based survey, the current practice of BP measurement and
Externí odkaz:
https://doaj.org/article/112b3b7c3412498b986bf686ff7a4391
Publikováno v:
Journal of Education and Health Promotion, Vol 9, Iss 1, Pp 34-34 (2020)
INTRODUCTION: The principal objective of clinical guidelines is to improve the quality of medical care. However, standardized evaluation of the adoption into daily practice is missing. The aim of our study was to investigate the implementation of gui
Externí odkaz:
https://doaj.org/article/30da243be93a471994b2b2a3a5bc68e6
Autor:
Roland E. Schmieder, Sven Wassmann, Hans-Georg Predel, Burkhard Weisser, Jörg Blettenberg, Anton Gillessen, Olaf Randerath, Antje Mevius, Thomas Wilke, Michael Böhm
Publikováno v:
Hypertension. 80:1127-1135
Background: Single-pill combination improves adherence and persistence to medication in hypertension. It remains unclear whether this also reduces cardiovascular outcomes and all-cause mortality. We analyzed whether single-pill combinations are super
Autor:
Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland E Schmieder, Sven Wassmann, Anton Gillessen, Jörg Blettenberg, Ulf Maywald, Olaf Randerath, Sabrina Müller, Michael Böhm
Aim: This study assessed whether a single pill combination (SPC) is associated with lower direct healthcare costs. Materials & methods: Anonymized claims data of patients ≥18 years treated with drugs for cardiovascular (CV)-related diseases either
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c844966965b3d28af77226ed03187d
Autor:
Thomas Wilke, Burkhard Weisser, Hans-Georg Predel, Roland E Schmieder, Sven Wassmann, Anton Gillessen, Jörg Blettenberg, Ulf Maywald, Olaf Randerath, Sabrina Mueller, Michael Böhm
Publikováno v:
Integrated Blood Pressure Control.
Thomas Wilke,1 Burkhard Weisser,2 Hans-Georg Predel,3 Roland Schmieder,4 Sven Wassmann,5 Anton Gillessen,6 Jörg Blettenberg,7 Ulf Maywald,8 Olaf Randerath,9 Sabrina Mueller,10 Michael Böhm11 1Institut für Pharmakoökonomie und Arzneimittel
Autor:
Burkhard Weisser, Andrea Noetel, Claudia Hacke, Olaf Randerath, Johannes Vor dem Esche, Hans-Georg Predel, Gerd Rippin, Anton Gillessen
Publikováno v:
High Blood Pressure & Cardiovascular Prevention
Introduction Cardiovascular diseases (CVD) represent the first cause of mortality in western countries. Hypertension and dyslipidemia are strong risk factors for CVD, and are prevalent either alone or in combination. Although effective substances for
Publikováno v:
Clinical pharmacology in drug developmentReferences. 10(2)
For efficient cardiovascular risk protection antihypertensive treatment is often combined with cholesterol-lowering treatment, although solid data of interaction and side effects are missing. This is a prospective, single-center interaction study con
Autor:
B. Weisser, Sven Wassmann, Michael Böhm, Roland E. Schmieder, Olaf Randerath, Andrea Noetel, Hans-Georg Predel, Jörg Blettenberg, Valérie Fournier, Anton Gillessen
Publikováno v:
Journal of Hypertension. 39:e378
Publikováno v:
Current medical research and opinion 28(7), 1239-1246 (2012). doi:10.1185/03007995.2012.702101
Knowledge of patients' treatment needs is an important requirement for comprehensive long-term patient care. The objective of this investigation was to assess the requirements of patients with Parkinson's disease (PD) regarding pharmacotherapy.A tota
Autor:
Olaf Randerath
Publikováno v:
Deutsche Zeitschrift für Onkologie. 33:51-56